FDA Approves Zynrelef (bupivacaine and meloxicam) for the Management of Postoperative Pain

Article Link: FDA Approves Zynrelef (bupivacaine and meloxicam) for the Management of Postoperative Pain

SAN DIEGO, May 13, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet…

Source: FDA New Drug Approvals